Immunic, Inc. (IMUX)

Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	97.31	46.67	106.75	86.86	127.45	29.37
Short-Term Investments	0	0	9.63	0	0	0
Cash & Cash Equivalents	97.31	46.67	116.37	86.86	127.45	29.37
Cash Growth	0.21%	-59.89%	33.97%	-31.85%	333.97%	124.67%
Other Current Assets	5.3	5.86	9.49	18.13	6.29	2.86
Total Current Assets	102.62	52.53	125.86	104.99	133.75	32.23
Property, Plant & Equipment	1.54	1.77	1.85	1.1	1.1	0.71
Goodwill and Intangibles	0	0	0	32.97	32.97	32.97
Other Long-Term Assets	0	0	0.04	0.04	0.04	0.04
Total Long-Term Assets	1.54	1.77	1.89	34.11	34.12	33.73
Total Assets	104.16	54.3	127.75	139.1	167.86	65.96
Accounts Payable	6.77	5.1	4.28	3.75	3.7	2.42
Other Current Liabilities	13.38	19.63	8.8	7.66	4.7	4.65
Total Current Liabilities	20.15	24.73	13.08	11.4	8.4	7.07
Long-Term Debt	0.43	0.64	0.99	0.58	0.68	0.52
Total Long-Term Liabilities	0.43	0.64	0.99	0.58	0.68	0.52
Total Liabilities	20.58	25.37	14.07	11.99	9.08	7.59
Total Debt	0.43	0.64	0.99	0.58	0.68	0.52
Debt Growth	-67.97%	-35.58%	69.86%	-13.99%	30.58%	-
Retained Earnings	-440.48	-410.89	-317.28	-196.87	-103.93	-59.91
Comprehensive Income	4.29	3.76	3.04	-0.25	-4.11	-1.37
Shareholders' Equity	83.58	28.93	113.68	127.12	158.79	58.36
Net Cash / Debt	96.88	46.04	115.38	86.28	126.77	28.85
Net Cash / Debt Growth	1.17%	-60.10%	33.73%	-31.94%	339.44%	120.69%
Net Cash Per Share	1.00	1.04	3.63	3.65	8.09	3.74
Working Capital	82.47	27.81	112.79	93.59	125.35	25.16
Book Value Per Share	0.86	0.65	3.57	5.37	10.14	7.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).